Menu
Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 1 » default
ISSN: 1179-9900
- View all (139)
- Volume 15, 2025 (4)
- Volume 14, 2024 (11)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Archive: Volume 1, 2011
Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab
Niino M
Degenerative Neurological and Neuromuscular Disease 2011, 1:33-42
Published Date: 3 October 2011
Profile of oral laquinimod and its potential in the treatment of multiple sclerosis
West MS, Miravalle A
Degenerative Neurological and Neuromuscular Disease 2011, 1:25-32
Published Date: 22 July 2011
Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids
Ashton JC
Degenerative Neurological and Neuromuscular Disease 2011, 1:15-23
Published Date: 17 June 2011
Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease
Singh I, Grossberg GT
Degenerative Neurological and Neuromuscular Disease 2011, 1:9-13
Published Date: 10 June 2011
Evaluation of glycopyrrolate in the treatment of chronic drooling
Reddihough DS, Reid SM, Plover C
Degenerative Neurological and Neuromuscular Disease 2011, 1:3-7
Published Date: 18 May 2011
Editorial
Glenn Lopate
Degenerative Neurological and Neuromuscular Disease 2011, 1:1-2
Published Date: 18 March 2011